Differential Role for Hippocampal Subfields in Alzheimer's Disease Progression Revealed with Deep Learning

Insights

Deep learning identified key hippocampal subfields contributing to mild cognitive impairment (MCI) progression. This reveals specific regions critical for differentiating stable versus progressive MCI, offering new insights into Alzheimer's disease development.

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Mild cognitive impairment (MCI) is a potential precursor to Alzheimer's disease, but its progression varies significantly.
  • Current research on MCI progression often overlooks the detailed structure and subdivisions of the hippocampus.
  • Understanding hippocampal subfield contributions is crucial for predicting MCI trajectory.

Purpose of the Study:

  • To investigate the role of specific hippocampal subfields in differentiating between stable and progressive mild cognitive impairment (MCI).
  • To develop and validate a deep learning model for predicting MCI progression based on hippocampal morphometry.

Main Methods:

  • Utilized a dense convolutional neural network (CNN) architecture for analyzing hippocampal morphometry.
  • Employed a novel occlusion analysis to determine the contribution of individual hippocampal subfields to model performance.
  • Assessed the model's accuracy in differentiating stable from progressive MCI.

Main Results:

  • The deep learning model achieved an accuracy of 75.85% in distinguishing between stable and progressive MCI.
  • Occlusion analysis identified the presubiculum, CA1, subiculum, and molecular layer as critical subfields for prediction.
  • Found that 10.5% of hippocampal volume was redundant for differentiating MCI progression.

Conclusions:

  • Deep learning models can effectively utilize hippocampal morphometry to predict MCI progression.
  • Specific hippocampal subfields play a disproportionately important role in the transition from stable MCI to progressive MCI.
  • These findings highlight the potential of detailed hippocampal subfield analysis for early detection and understanding of Alzheimer's disease pathogenesis.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
879
Role of Hippocampus in Memory01:19

Role of Hippocampus in Memory

The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
680
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
419